Longevity
Can Removing "Zombie Cells" Slow Aging? Human Clinical Trials Are Starting to Deliver Answers
Senolytics — drugs that selectively eliminate senescent cells — have moved from mouse experiments to human clinical trials across kidney disease, Alzheimer's, and frailty. Here is an honest account of what 80-plus trials are finding.
This story was reported by Medical Daily. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Medical Daily →